| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |